People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mannkind Corp | — | Pharmaceuticals | Series C | $58.9M | $2.1B | 2013 |
JUERGEN A MARTENS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JUERGEN A MARTENS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| HENRY L NORDHOFF | 1 | 3 |
| ALFRED E MANN | 1 | 2 |
| DAVID H MACCALLUM | 1 | 2 |
| MATTHEW J PFEFFER | 1 | 1 |
| RONALD B CONSIGLIO | 1 | 1 |
| HAKAN S EDSTROM | 1 | 1 |
| DAVID B THOMSON | 1 | 1 |
| MICHAEL B FRIEDMAN | 1 | 1 |
| KENT B KRESA | 1 | 1 |
| DIANE M PALUMBO | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.